# Evaluation of NWRD09 for HPV-16 Related Cervical HSIL

> clinical trial · VERIFIED · 2026-07-17

Status: NOT_YET_RECRUITING · Sponsor: Newish Biotech (Wuxi) Co., Ltd. · Condition: High-grade Squamous Intraepithelial Lesion (HSIL)

- Company: Newish Biotech (Wuxi) Co., Ltd.
- Sector: High-grade Squamous Intraepithelial Lesion (HSIL)
- Primary source: https://clinicaltrials.gov/study/NCT07712692

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.